Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

Short summary

Buprenorphine maintenance treatment is superior to placebo in retaining patients and suppressing illicit opioid use at higher doses (≥ 16 mg), but less effective than methadone in retaining patients when doses are flexibly delivered or low fixed doses are used.

AI-generated from the title and abstract; the full text is not read.